Ask a Question

User masspotato29

Member for: 2 weeks (since Apr 28)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/a939572.html
About: Adjuvant ruxolitinib treatment reduces steroid-refractory cytokine-release syndrome without having hampering chimeric antigen receptor-modified T-cell operate.

Activity by masspotato29

Score: 100 points (ranked #79)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for masspotato29

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...